Association between Dopamine Receptor D2 (DRD2) Variations rs6277 and rs1800497 and Cognitive Performance According to Risk Type for Psychosis: A Nested Case Control Study in a Finnish Population Sample.
Barnett, Jennifer H
Murray, Graham K
Affiliation1Department of Psychiatry, Centre for Clinical Neuroscience, University of Oulu, Oulu, Finland; Health Service Executive, Dublin, Ireland.
MetadataShow full item record
CitationAssociation between Dopamine Receptor D2 (DRD2) Variations rs6277 and rs1800497 and Cognitive Performance According to Risk Type for Psychosis: A Nested Case Control Study in a Finnish Population Sample. 2015, 10 (6):e0127602 PLoS ONE
AbstractThere is limited research regarding the association between genes and cognitive intermediate phenotypes in those at risk for psychotic disorders.
We measured the association between established psychosis risk variants in dopamine D2 receptor (DRD2) and cognitive performance in individuals at age 23 years and explored if associations between cognition and these variants differed according to the presence of familial or clinical risk for psychosis. The subjects of the Oulu Brain and Mind Study were drawn from the general population-based Northern Finland 1986 Birth Cohort (NFBC 1986). Using linear regression, we compared the associations between cognitive performance and two candidate DRD2 polymorphisms (rs6277 and rs1800497) between subjects having familial (n=61) and clinical (n=45) risk for psychosis and a random sample of participating NFBC 1986 controls (n=74). Cognitive performance was evaluated using a comprehensive battery of tests at follow-up.
Principal components factor analysis supported a three-factor model for cognitive measures. The minor allele of rs6277 was associated with poorer performance on a verbal factor (p=0.003) but this did not significantly interact with familial or clinical risk for psychosis. The minor allele of rs1800497 was associated with poorer performance on a psychomotor factor (p=0.038), though only in those at familial risk for psychotic disorders (interaction p=0.049).
The effect of two DRD2 SNPs on cognitive performance may differ according to risk type for psychosis, suggesting that cognitive intermediate phenotypes differ according to the type (familial or clinical) risk for psychosis.
- DRD3, but not COMT or DRD2, genotype affects executive functions in healthy and first-episode psychosis adolescents.
- Authors: Bombin I, Arango C, Mayoral M, Castro-Fornieles J, Gonzalez-Pinto A, Gonzalez-Gomez C, Moreno D, Parellada M, Baeza I, Graell M, Otero S, Saiz PA, Patiño-Garcia A
- Issue date: 2008 Sep 5
- Single nucleotide polymorphisms in ANKK1 and the dopamine D2 receptor gene affect cognitive outcome shortly after traumatic brain injury: a replication and extension study.
- Authors: McAllister TW, Flashman LA, Harker Rhodes C, Tyler AL, Moore JH, Saykin AJ, McDonald BC, Tosteson TD, Tsongalis GJ
- Issue date: 2008 Aug
- Association analyses for dopamine receptor gene polymorphisms and weight status in a longitudinal analysis in obese children before and after lifestyle intervention.
- Authors: Roth CL, Hinney A, Schur EA, Elfers CT, Reinehr T
- Issue date: 2013 Nov 27
- DRD2 C957T polymorphism is associated with improved 6-month verbal learning following traumatic brain injury.
- Authors: Yue JK, Winkler EA, Rick JW, Burke JF, McAllister TW, Oh SS, Burchard EG, Hu D, Rosand J, Temkin NR, Korley FK, Sorani MD, Ferguson AR, Lingsma HF, Sharma S, Robinson CK, Yuh EL, Tarapore PE, Wang KK, Puccio AM, Mukherjee P, Diaz-Arrastia R, Gordon WA, Valadka AB, Okonkwo DO, Manley GT, TRACK-TBI Investigators.
- Issue date: 2017 Jan
- Association between polymorphisms of the dopamine receptor D2 and catechol-o-methyl transferase genes and cognitive function.
- Authors: Bolton JL, Marioni RE, Deary IJ, Harris SE, Stewart MC, Murray GD, Fowkes FG, Price JF
- Issue date: 2010 Sep